Biotech: Page 45
-
Talent Pool
Pharmaceutical POOL Deirdre CONNELLY GlaxoSmithKline Selects Head of North American Pharma Business Deirdre Connelly, former president of U.S. operations at Eli Lilly, has joined GlaxoSmithKline (GSK) as president, North American pharmaceuticals. Ms. Connelly was appointed president of U.S. opera...
By PharmaVoice Team • Feb. 26, 2009 -
What's New
New healthcare-related products, services, and companies GfK Consolidates Market Research Operations Operating as one entity allows GfK Healthcare to pull together its strengths and individual leadership positions across multi-client research. The GfK U.S. Healthcare Companies has consolidated it...
By PharmaVoice Team • Feb. 26, 2009 -
Trendline
Commercialization, marketing and social media
As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.
By PharmaVoice staff -
Talent Pool
TALENT POOL EXECUTIVE APPOINTMENTS AND PROMOTIONS IN THE HEALTHCARE INDUSTRY Pharma POOL Lamberto ANDREOTTI Dr. Andrew G. BODNAR Donald J. HAYDEN Dr. James B. D. PALMER Thomas J. PICKARD David L. ZABOR Bristol-Myers Squibb Announces New Senior Leadership Team — Appoints Former GlaxoSmithKline V...
By PharmaVoice Team • Feb. 23, 2009 -
Table of Contents
4 S e p t e m be r / O c t o b e r 2 00 1 PharmaVOICE The promise of things to come The Internet’s future potential is in its infinite ability to allow marketers to develop personalized messages 48 Conquering the market, one segment at a time Cytyc’s launch of the ThinPrep System is making an imp...
By PharmaVoice Team • Feb. 16, 2009 -
What's New
WHAT’S NEW NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES The OmniLog ID Microbial Identification System, which includes proprietary software and sophisticat ed hardware, is designed to automate and simplify the process of characterizing and identifying a wide range of aerobic bacteria. ...
By PharmaVoice Team • Feb. 12, 2009 -
PharmaTrax
Drug Delivery’s RISE CHALLENGES Big Pharma’s Dominance Set to soar from just $2.4 billion to about $12 billion in just five years, the value of drug delivery technologies and the market clout of developers are making established pharmaceutical giants sit up and take notice, according to a study r...
By PharmaVoice Team • Feb. 12, 2009 -
Table of Contents
6 J u l y / A u gu s t 20 01 PharmaVOICE CSOs: Not just hired guns Contract sales organizations have come a long way to stay a step ahead of their clients’ needs 34 Unleashing the power of Nexium AstraZeneca marketers are positioning the company’s new proton pump inhibitor to replace Prilosec, th...
By PharmaVoice Team • Feb. 11, 2009 -
Agency Pitches — In Need of an Umpire
BY Taren Grom THE STARTING LINEUP … RYANABBATE. President and managing director, Pacific Communications,Costa Mesa,Calif. ARTHUR ANDERSON.Managing principal, Morgan Anderson Consulting, NewYork SCOTT COTHERMAN. President and CEO,Corbett Healthcare Group,Chicago RODHANLON. Chairman,Wanamaker Assoc...
By PharmaVoice Team • Feb. 11, 2009 -
Between Two Coasts
VIEW on Biotech Hoping to transform the rust belt into the Biotech belt, Michael Rosen, is spearheading an initiative to make the Midwest a mecca for biotech activity. IN AN EXCLUSIVE INTERVIEW WITH PHARMAVOICE, MICHAEL ROSEN,PRESIDENT AND CEO OF ENDOREX CORP. AND CO-CHAIRMAN OF THE BOARD OF THE ...
By PharmaVoice Team • Feb. 11, 2009 -
A Piece of the Pie
Calling all marketers: don’t cancel those journal ads just yet, it may be time to evaluate the overall marketing mix for your brand’s promotion. Before brand managers and media directors make their next decision on how to divide up their promotional budget, they should consider the results of a c...
By PharmaVoice Team • Feb. 10, 2009 -
Talent Pool
Dr.. Hubertus ERLEN New Schering AG CEO named to replace Dr.Vita who retired Dr. Hubertus Erlen has assumed the chairmanship of the executive board of Scher ing AG, suc ceeding Dr. Giuseppe Vita, who retired after 12 years as chairman. Schering AG is a researchbased pharma ceutical company, focus...
By PharmaVoice Team • Feb. 10, 2009 -
What's New
“The Catalyst system allows an advertiser to pro vide customers with specific information that has been tailored to the answers they provide and is writ ten in a style they’re comfortable with,” says David Sadock,VP, marketing and sales, HealthAnswers Inc., Pennington, N.J. “Regardless of whether...
By PharmaVoice Team • Feb. 10, 2009 -
Letter from the Editor
PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh CONTRIBUTING EDITORS Diane Hoffman Virginia Kirk Denise Myshko Lynda Sears Copyright 2001 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume One, Number One PharmaVoice is published six times per year by PharmaLinx ...
By Taren Grom • Feb. 10, 2009 -
Table of Contents
We invite you to explore the digital edition of PharmaVOICE magazine. The interactive format allows you to easily read, share with friends, and click on podcasts, videos, webinars, whitepapers, and Website links to access additional resources. Getting started with your digital edition is this eas...
By PharmaVoice Team • Jan. 28, 2009 -
From the Heart: Personal Stories, Public Causes
BY KIM RIBBINK The expression the acorn becomes an oak is never truer than in charitable and philanthropic acts. Individuals who are moved by a certain cause — as a result of their own experiences, beliefs, or outlooks — often inspire many others to rally to that cause. Last year,PharmaVOICE bega...
By PharmaVoice Team • Jan. 28, 2009 -
Last Word
We are honored to receive this prestigious Enterprise award from Eastern Technology Council, says Robert Broeze, Ph.D., President and CEO of Laureate Pharma. Dr. Broeze, who is with Dr. Michiel Ultee, VP of Process Sciences, in front of an Applikon 20L Bioreactor, says the award validates the com...
By PharmaVoice Team • Jan. 28, 2009 -
Talent Pool
Pharma POOL William GARBARINI Jr. Ferring Promotes Head of Orthopedics and Urology Business Ferring Pharmaceuticals has promoted William Garbarini Jr. to VP of its orthopedics and urology business unit, recently formed by the merging of these clinical product areas. Mr. Garbarini was formerly exe...
By PharmaVoice Team • Jan. 28, 2009 -
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Lathian Health Offers Closed-Loop Promotion Tool Informa Launches CRM/ROI Tracking Solution Verticals onDemand Offers Analytics and Reporting Solution OpenQ Unveils KOL Solutions Tibco Spotfire Solution Speeds Dru...
By PharmaVoice Team • Jan. 27, 2009 -
Partnering for Success
Mitigate risk by reading red flags Creating effective partnerships is more crucial than ever, so being able to spot red flags from a distance, and knowing how to deal with potential problems close up is of great value today. Careful planning, goal setting, and communication can improve the succes...
By PharmaVoice Team • Dec. 30, 2008 -
Table of Contents
ON THE COVER Partnering for Success In these times of adversity, strategic alliances become even more crucial than ever for survival. FEATURES No Pens or Mugs? No Problem. The industry is discovering it won’t lose the ability to message effectively under the new PhRMA code. The Green o...
By PharmaVoice Team • Dec. 22, 2008 -
Reaching The Higher Ground Through Higher Education
With the economy in turmoil and job cuts at the highest level since 2002, the pharmaceutical industry is under extreme pressures — layoffs, increased regulatory scrutiny, generic competition, pricing constraints, escalating R&D costs, etc. To thrive, no less survive, in these trying times, co...
By Denise Myshko • Dec. 22, 2008 -
John Crowley — Journey of the Heart
When presented with shocking news concerning the health of his two youngest children, John Crowley responded by embarking on a mission to help uncover a novel therapeutic option for treating Pompe disease, a lysosomal storage disease (LSD) that, like other LSDs, interferes with the body’s ability...
By PharmaVoice Team • Dec. 22, 2008 -
The Benefits of Prelaunch Access
Contributed by Natalie Douglas, CEO, IDIS Prelaunch access to drugs can provide months and perhaps years of treatment for patients with unmet medical needs when all other therapeutic options have failed or no other options are available. The benefits of named- patient programs are best realized w...
By Natalie Douglas • Dec. 22, 2008 -
Last Word
Sirtris’ Dr. Michelle Dipp discusses maintaining corporate culture while integrating cutting-edge science and technology. Biotech business leader Michelle Dipp, M.D., Ph.D., has transitioned from a scientific background — with a medical degree and a Ph.D. — to the corporate side of the life-scien...
By PharmaVoice Team • Dec. 22, 2008 -
Talent Pool
Pharmaceutical POOL Alex Gorsky Sheri McCoy Johnson & Johnson Shifts Executives Global healthcare company Johnson & Johnson has appointed Alex Gorsky worldwide chairman, surgical care group, with responsibility for the surgical franchises Ethicon, Ethicon Endo-Surgery, and DePuy, as well ...
By PharmaVoice Team • Dec. 22, 2008